[HTML][HTML] Human CD8+ T-cell populations that express natural killer receptors

JY Koh, DU Kim, BH Moon, EC Shin - Immune Network, 2023 - ncbi.nlm.nih.gov
CD8+ T cells are activated by TCRs that recognize specific cognate Ags, while NK-cell
activation is regulated by a balance between signals from germline-encoded activating and …

[HTML][HTML] Epigenetic orchestration of host immune defences by Mycobacterium tuberculosis

S Sengupta, KP Pattanaik, S Mishra… - Microbiological …, 2023 - Elsevier
Being among the top 10 causes of adult deaths, tuberculosis (TB) disease is considered a
major global public health concern to address. The human tuberculosis pathogen …

Complete sequencing of a cynomolgus macaque major histocompatibility complex haplotype

JA Karl, TM Prall, HE Bussan, JM Varghese… - Genome …, 2023 - genome.cshlp.org
Macaques provide the most widely used nonhuman primate models for studying the
immunology and pathogenesis of human diseases. Although the macaque major …

Extensive flow cytometric immunophenotyping of human PBMC incorporating detection of chemokine receptors, cytokines and tetramers

M van Wolfswinkel, KE van Meijgaarden… - Cytometry Part …, 2023 - Wiley Online Library
Abstract Characterization of immune cells is essential to advance our understanding of
immunology and flow cytometry is an important tool in this context. Addressing both cellular …

Cryptic MHC-E epitope from influenza elicits a potent cytolytic T cell response

MJ Hogan, N Maheshwari, BE Begg, A Nicastri… - Nature …, 2023 - nature.com
The extent to which unconventional forms of antigen presentation drive T cell immunity is
unknown. By convention, CD8 T cells recognize viral peptides, or epitopes, in association …

Graft-versus-tumor effect of post-transplant cyclophosphamide-based allogeneic hematopoietic cell transplantation

H Nakamae - Frontiers in Immunology, 2024 - frontiersin.org
Post-transplant cyclophosphamide (PTCy) is becoming the standard prophylaxis for graft-
versus-host disease (GVHD) in HLA-haploidentical allogeneic hematopoietic cell …

[HTML][HTML] The antibodies 3D12 and 4D12 recognise distinct epitopes and conformations of HLA-E

S Brackenridge, N John, K Früh, P Borrow… - Frontiers in …, 2024 - frontiersin.org
The commonly used antibodies 3D12 and 4D12 recognise the human leukocyte antigen E
(HLA-E) protein. These antibodies bind distinct epitopes on HLA-E and differ in their ability …

[HTML][HTML] Instability of the HLA-E peptidome of HIV presents a major barrier to therapeutic targeting

Z Wallace, T Heunis, RL Paterson, RJ Suckling… - Molecular Therapy, 2024 - cell.com
Naturally occurring T cells that recognize microbial peptides via HLA-E, a nonpolymorphic
HLA class Ib molecule, could provide the foundation for new universal immunotherapeutics …

[HTML][HTML] Mtb HLA-E-tetramer-sorted CD8+ T cells have a diverse TCR repertoire

L Voogd, AMHF Drittij, CKE Dingenouts… - Iscience, 2024 - cell.com
HLA-E molecules can present self-and pathogen-derived peptides to both natural killer (NK)
cells and T cells. T cells that recognize HLA-E peptides via their T cell receptor (TCR) are …

[HTML][HTML] Nanotechnology-Based RNA Vaccines: Fundamentals, Advantages and Challenges

VP Pozharov, T Minko - Pharmaceutics, 2023 - mdpi.com
Over the past decades, many drugs based on the use of nanotechnology and nucleic acids
have been developed. However, until recently, most of them remained at the stage of pre …